|
|
||||||||
-Deficient Mice in Chronic Leishmaniasis Reveal a Protective Role for IL-13 Receptor Signaling1


*
Max-Planck-Institute for Immunobiology, Freiburg, Germany;
Novartis Pharma Ltd., Basel, Switzerland;
Department of Pathology, University Freiburg, Freiburg, Germany;
§
Institute for Clinical Microbiology and Immunology, University Erlangen, Erlangen, Germany; and
¶
Department of Immunology, University of Cape Town, Cape Town, South Africa
IL-4 receptor
-chain-deficient (IL-4R
-/-) mice
were generated by homologous and site-specific recombination, using the
Cre/loxP system in BALB/c-derived embryonic stem cells. In vitro
analysis of cells from these mice revealed impaired IL-4- and
IL-13-mediated functions, demonstrating that the IL-4R
-chain is an
essential component of both the IL-4 and the IL-13 receptor. Whereas
Leishmania major-infected BALB/c mice developed fatal
progressive disease with type 2 Ab responses within 3 mo, both
IL-4R
-/- and IL-4-/- BALB/c mice
contained infection with reduced footpad swelling, parasite load,
moderate histopathology, and type 1 Ab responses during this time
period. Conclusively, these results demonstrate an IL-4-dependent
mechanism of susceptibility in BALB/c mice. Nevertheless, in contrast
to mutant mice, infected C57BL/6 mice healed completely within 3 mo,
indicating that additional factors are necessary for subsequent healing
and elimination of the pathogen. During the further course of
infection, IL-4R
-/- mice developed progressive disease
with massive footpad swelling. Lesions became ulcerative and necrotic
with subsequent destruction of connective tissue and bones, as well as
dissemination into organs and consequent mortality within the monitored
6 mo of chronic infection. In striking contrast, IL-4-/-
mice maintained control of infection on a moderate level, but were
unable to clear the pathogen. The distinct phenotypes of the BALB/c
embryonic stem cell-derived IL-4-/- and
IL-4R
-/- mouse strains identify previously unsuspected
mechanisms for maintaining host immunity to chronic infection with
L. major, mediated by a functional IL-13
receptor.
This article has been cited by other articles:
![]() |
F. Benhnini, M. Chenik, D. Laouini, H. Louzir, P. A. Cazenave, and K. Dellagi Comparative Evaluation of Two Vaccine Candidates against Experimental Leishmaniasis Due to Leishmania major Infection in Four Inbred Mouse Strains Clin. Vaccine Immunol., November 1, 2009; 16(11): 1529 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Everts, G. Perona-Wright, H. H. Smits, C. H. Hokke, A. J. van der Ham, C. M. Fitzsimmons, M. J. Doenhoff, J. van der Bosch, K. Mohrs, H. Haas, et al. Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses J. Exp. Med., August 3, 2009; 206(8): 1673 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dewals, J. C. Hoving, M. Leeto, R. G. Marillier, U. Govender, A. J. Cutler, W. G.C. Horsnell, and F. Brombacher IL-4R{alpha} Responsiveness of Non-CD4 T Cells Contributes to Resistance in Schistosoma mansoni Infection in Pan-T Cell-Specific IL-4R{alpha}-Deficient Mice Am. J. Pathol., August 1, 2009; 175(2): 706 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. King and M. Mohrs IL-4-producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells J. Exp. Med., May 11, 2009; 206(5): 1001 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Steenwinckel, J. Louahed, M. M. Lemaire, C. Sommereyns, G. Warnier, A. McKenzie, F. Brombacher, J. Van Snick, and J.-C. Renauld IL-9 Promotes IL-13-Dependent Paneth Cell Hyperplasia and Up-Regulation of Innate Immunity Mediators in Intestinal Mucosa J. Immunol., April 15, 2009; 182(8): 4737 - 4743. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Stenzel, U. Muller, G. Kohler, F. L. Heppner, M. Blessing, A. N.J. McKenzie, F. Brombacher, and G. Alber IL-4/IL-13-Dependent Alternative Activation of Macrophages but Not Microglial Cells Is Associated with Uncontrolled Cerebral Cryptococcosis Am. J. Pathol., February 1, 2009; 174(2): 486 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mearns, W. G. C. Horsnell, J. C. Hoving, B. Dewals, A. J. Cutler, F. Kirstein, E. Myburgh, B. Arendse, and F. Brombacher Interleukin-4-Promoted T Helper 2 Responses Enhance Nippostrongylus brasiliensis-Induced Pulmonary Pathology Infect. Immun., December 1, 2008; 76(12): 5535 - 5542. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kurowska-Stolarska, P. Kewin, G. Murphy, R. C. Russo, B. Stolarski, C. C. Garcia, M. Komai-Koma, N. Pitman, Y. Li, A. N. J. McKenzie, et al. IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4 J. Immunol., October 1, 2008; 181(7): 4780 - 4790. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Shirey, L. E. Cole, A. D. Keegan, and S. N. Vogel Francisella tularensis Live Vaccine Strain Induces Macrophage Alternative Activation as a Survival Mechanism J. Immunol., September 15, 2008; 181(6): 4159 - 4167. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Wheat, K. E. Pauken, R. V. Morris, and R. G. Titus Lutzomyia longipalpis Salivary Peptide Maxadilan Alters Murine Dendritic Cell Expression of CD80/86, CCR7, and Cytokine Secretion and Reprograms Dendritic Cell-Mediated Cytokine Release from Cultures Containing Allogeneic T Cells J. Immunol., June 15, 2008; 180(12): 8286 - 8298. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Basu, S. Bhaumik, A. K. Haldar, K. Naskar, T. De, S. K. Dana, P. Walden, and S. Roy Hybrid Cell Vaccination Resolves Leishmania donovani Infection by Eliciting a Strong CD8+ Cytotoxic T-Lymphocyte Response with Concomitant Suppression of Interleukin-10 (IL-10) but Not IL-4 or IL-13 Infect. Immun., December 1, 2007; 75(12): 5956 - 5966. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hayashi, K. Hasegawa, Y. Sasaki, T. Mori, C. Adachi, and K. Maeda Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZW F1 mice Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3131 - 3138. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schwegmann, R. Guler, A. J. Cutler, B. Arendse, W. G. C. Horsnell, A. Flemming, A. H. Kottmann, G. Ryan, W. Hide, M. Leitges, et al. Protein kinase C {delta} is essential for optimal macrophage-mediated phagosomal containment of Listeria monocytogenes PNAS, October 9, 2007; 104(41): 16251 - 16256. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Loke, I. Gallagher, M. G. Nair, X. Zang, F. Brombacher, M. Mohrs, J. P. Allison, and J. E. Allen Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection J. Immunol., September 15, 2007; 179(6): 3926 - 3936. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Misson, F. Brombacher, M. Delos, D. Lison, and F. Huaux Type 2 immune response associated with silicosis is not instrumental in the development of the disease Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L107 - L113. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Michels, P. Goyal, N. Nieuwenhuizen, and F. Brombacher Infection with Syphacia obvelata (Pinworm) Induces Protective Th2 Immune Responses and Influences Ovalbumin-Induced Allergic Reactions. Infect. Immun., October 1, 2006; 74(10): 5926 - 5932. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hassanzadeh Ghassabeh, P. De Baetselier, L. Brys, W. Noel, J. A. Van Ginderachter, S. Meerschaut, A. Beschin, F. Brombacher, and G. Raes Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions Blood, July 15, 2006; 108(2): 575 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Murray, C. W. Tsai, J. Liu, and X. Ma Visceral Leishmania donovani Infection in Interleukin-13-/- Mice Infect. Immun., April 1, 2006; 74(4): 2487 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J R McDermott, F C Leslie, M D'Amato, D G Thompson, R K Grencis, and J T McLaughlin Immune control of food intake: enteroendocrine cells are regulated by CD4+ T lymphocytes during small intestinal inflammation Gut, April 1, 2006; 55(4): 492 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pace, S. Rizzo, C. Palombi, F. Brombacher, and G. Doria Cutting Edge: IL-4-Induced Protection of CD4+CD25- Th Cells from CD4+CD25+ Regulatory T Cell-Mediated Suppression J. Immunol., April 1, 2006; 176(7): 3900 - 3904. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Holscher, B. Arendse, A. Schwegmann, E. Myburgh, and F. Brombacher Impairment of Alternative Macrophage Activation Delays Cutaneous Leishmaniasis in Nonhealing BALB/c Mice J. Immunol., January 15, 2006; 176(2): 1115 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kuperman, X. Huang, L. Nguyenvu, C. Holscher, F. Brombacher, and D. J. Erle IL-4 Receptor Signaling in Clara Cells Is Required for Allergen-Induced Mucus Production J. Immunol., September 15, 2005; 175(6): 3746 - 3752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. McDermott, N. E. Humphreys, S. P. Forman, D. D. Donaldson, and R. K. Grencis Intraepithelial NK Cell-Derived IL-13 Induces Intestinal Pathology Associated with Nematode Infection J. Immunol., September 1, 2005; 175(5): 3207 - 3213. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Murray, K. C. Flanders, D. D. Donaldson, J. P. Sypek, P. J. Gotwals, J. Liu, and X. Ma Antagonizing Deactivating Cytokines To Enhance Host Defense and Chemotherapy in Experimental Visceral Leishmaniasis Infect. Immun., July 1, 2005; 73(7): 3903 - 3911. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Raes, R. Van den Bergh, P. De Baetselier, G. H. Ghassabeh, C. Scotton, M. Locati, A. Mantovani, and S. Sozzani Arginase-1 and Ym1 Are Markers for Murine, but Not Human, Alternatively Activated Myeloid Cells J. Immunol., June 1, 2005; 174(11): 6561 - 6562. [Full Text] [PDF] |
||||
![]() |
L. Brys, A. Beschin, G. Raes, G. H. Ghassabeh, W. Noel, J. Brandt, F. Brombacher, and P. D. Baetselier Reactive Oxygen Species and 12/15-Lipoxygenase Contribute to the Antiproliferative Capacity of Alternatively Activated Myeloid Cells Elicited during Helminth Infection J. Immunol., May 15, 2005; 174(10): 6095 - 6104. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Holscher, A. Holscher, D. Ruckerl, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, and S. Ehlers The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis J. Immunol., March 15, 2005; 174(6): 3534 - 3544. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Raes, L. Brys, B. K. Dahal, J. Brandt, J. Grooten, F. Brombacher, G. Vanham, W. Noel, P. Bogaert, T. Boonefaes, et al. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation J. Leukoc. Biol., March 1, 2005; 77(3): 321 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Arendse, J. Van Snick, and F. Brombacher IL-9 Is a Susceptibility Factor in Leishmania major Infection by Promoting Detrimental Th2/Type 2 Responses J. Immunol., February 15, 2005; 174(4): 2205 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gessner, K. Mohrs, and M. Mohrs Mast Cells, Basophils, and Eosinophils Acquire Constitutive IL-4 and IL-13 Transcripts during Lineage Differentiation That Are Sufficient for Rapid Cytokine Production J. Immunol., January 15, 2005; 174(2): 1063 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. C. Babay, H. Louzir, C. Kebaier, S. Boubaker, K. Dellagi, and P.-A. Cazenave Inbred Strains Derived from Feral Mice Reveal New Pathogenic Mechanisms of Experimental Leishmaniasis Due to Leishmania major Infect. Immun., August 1, 2004; 72(8): 4603 - 4611. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Seki, M. Miyazaki, W. Suzuki, K. Hayashi, K. Arima, E. Myburgh, K. Izuhara, F. Brombacher, and M. Kubo IL-4-Induced GATA-3 Expression Is a Time-Restricted Instruction Switch for Th2 Cell Differentiation J. Immunol., May 15, 2004; 172(10): 6158 - 6166. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saeftel, A. Krueger, S. Arriens, V. Heussler, P. Racz, B. Fleischer, F. Brombacher, and A. Hoerauf Mice Deficient in Interleukin-4 (IL-4) or IL-4 Receptor {alpha} Have Higher Resistance to Sporozoite Infection with Plasmodium berghei (ANKA) than Do Naive Wild-Type Mice Infect. Immun., January 1, 2004; 72(1): 322 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Debus, J. Glasner, M. Rollinghoff, and A. Gessner High Levels of Susceptibility and T Helper 2 Response in MyD88-Deficient Mice Infected with Leishmania major Are Interleukin-4 Dependent Infect. Immun., December 1, 2003; 71(12): 7215 - 7218. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stager, J. Alexander, K. C. Carter, F. Brombacher, and P. M. Kaye Both Interleukin-4 (IL-4) and IL-4 Receptor {alpha} Signaling Contribute to the Development of Hepatic Granulomas with Optimal Antileishmanial Activity Infect. Immun., August 1, 2003; 71(8): 4804 - 4807. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hackstein, T. Taner, A. F. Zahorchak, A. E. Morelli, A. J. Logar, A. Gessner, and A. W. Thomson Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo Blood, June 1, 2003; 101(11): 4457 - 4463. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. J. Pollock, K. S. McNeil, J. C. Mottram, R. E. Lyons, J. M. Brewer, P. Scott, G. H. Coombs, and J. Alexander The Leishmania mexicana Cysteine Protease, CPB2.8, Induces Potent Th2 Responses J. Immunol., February 15, 2003; 170(4): 1746 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mohrs, D. A. Lacy, and R. M. Locksley Stat Signals Release Activated Naive Th Cells from an Anergic Checkpoint J. Immunol., February 15, 2003; 170(4): 1870 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Akhiani, J. Pappo, Z. Kabok, K. Schon, W. Gao, L. E. Franzen, and N. Lycke Protection Against Helicobacter pylori Infection Following Immunization Is IL-12-Dependent and Mediated by Th1 Cells J. Immunol., December 15, 2002; 169(12): 6977 - 6984. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Noel, G. Hassanzadeh, G. Raes, B. Namangala, I. Daems, L. Brys, F. Brombacher, P. D. Baetselier, and A. Beschin Infection Stage-Dependent Modulation of Macrophage Activation in Trypanosoma congolense-Resistant and -Susceptible Mice Infect. Immun., November 1, 2002; 70(11): 6180 - 6187. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Anderson and D. M. Mosser A novel phenotype for an activated macrophage: the type 2 activated macrophage J. Leukoc. Biol., July 1, 2002; 72(1): 101 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Raes, P. De Baetselier, W. Noel, A. Beschin, F. Brombacher, and G. Hassanzadeh Gh. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages J. Leukoc. Biol., April 1, 2002; 71(4): 597 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Venkayya, M. Lam, M. Willkom, G. Grunig, D. B. Corry, and D. J. Erle The Th2 Lymphocyte Products IL-4 and IL-13 Rapidly Induce Airway Hyperresponsiveness Through Direct Effects on Resident Airway Cells Am. J. Respir. Cell Mol. Biol., February 1, 2002; 26(2): 202 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Eriksson, M. O. Kurrer, W. Sebald, F. Brombacher, and M. Kopf Dual Role of the IL-12/IFN-{gamma} Axis in the Development of Autoimmune Myocarditis: Induction by IL-12 and Protection by IFN-{gamma} J. Immunol., November 1, 2001; 167(9): 5464 - 5469. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lucas, D. Bumann, A. Walduck, J. Koesling, L. Develioglu, T. F. Meyer, and T. Aebischer Adoptive Transfer of CD4+ T Cells Specific for Subunit A of Helicobacter pylori Urease Reduces H. pylori Stomach Colonization in Mice in the Absence of Interleukin-4 (IL-4)/IL-13 Receptor Signaling Infect. Immun., March 1, 2001; 69(3): 1714 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Fort, R. Lesley, N. J. Davidson, S. Menon, F. Brombacher, M. W. Leach, and D. M. Rennick IL-4 Exacerbates Disease in a Th1 Cell Transfer Model of Colitis J. Immunol., February 15, 2001; 166(4): 2793 - 2800. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Mountford, K. G. Hogg, P. S. Coulson, and F. Brombacher Signaling via Interleukin-4 Receptor {alpha} Chain Is Required for Successful Vaccination against Schistosomiasis in BALB/c Mice Infect. Immun., January 1, 2001; 69(1): 228 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aebischer, S. Laforsch, R. Hurwitz, F. Brombacher, and T. F. Meyer Immunity against Helicobacter pylori: Significance of Interleukin-4 Receptor {alpha} Chain Status and Gender of Infected Mice Infect. Immun., January 1, 2001; 69(1): 556 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Houston, E. H. Wilson, L. Eyres, F. Brombacher, M. M. Harnett, J. Alexander, and W. Harnett Presence of Phosphorylcholine on a Filarial Nematode Protein Influences Immunoglobulin G Subclass Response to the Molecule by an Interleukin-10-Dependent Mechanism Infect. Immun., September 1, 2000; 68(9): 5466 - 5468. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Constant, C. Dong, D. D. Yang, M. Wysk, R. J. Davis, and R. A. Flavell JNK1 Is Required for T Cell-Mediated Immunity Against Leishmania major Infection J. Immunol., September 1, 2000; 165(5): 2671 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sato, S. K. Ahuja, M. Quinones, V. Kostecki, R. L. Reddick, P. C. Melby, W. A. Kuziel, and S. S. Ahuja Cc Chemokine Receptor (Ccr)2 Is Required for Langerhans Cell Migration and Localization of T Helper Cell Type 1 (Th1)-Inducing Dendritic Cells: Absence of Ccr2 Shifts the Leishmania major-Resistant Phenotype to a Susceptible State Dominated by Th2 Cytokines, B Cell Outgrowth, and Sustained Neutrophilic Inflammation J. Exp. Med., July 17, 2000; 192(2): 205 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Jones, L. U. Buxbaum, and P. Scott IL-4-Independent Inhibition of IL-12 Responsiveness During Leishmania amazonensis Infection J. Immunol., July 1, 2000; 165(1): 364 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Himmelrich, P. Launois, I. Maillard, T. Biedermann, F. Tacchini-Cottier, R. M. Locksley, M. Rocken, and J. A. Louis In BALB/c Mice, IL-4 Production During the Initial Phase of Infection with Leishmania major Is Necessary and Sufficient to Instruct Th2 Cell Development Resulting in Progressive Disease J. Immunol., May 1, 2000; 164(9): 4819 - 4825. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mohrs, C. Holscher, and F. Brombacher Interleukin-4 Receptor Alpha-Deficient BALB/c Mice Show an Unimpaired T Helper 2 Polarization in Response to Leishmania major Infection Infect. Immun., April 1, 2000; 68(4): 1773 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Matthews, C. L. Emson, G. J. McKenzie, H. E. Jolin, J. M. Blackwell, and A. N. J. McKenzie IL-13 Is a Susceptibility Factor for Leishmania major Infection J. Immunol., February 1, 2000; 164(3): 1458 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Brewer, M. Conacher, C. A. Hunter, M. Mohrs, F. Brombacher, and J. Alexander Aluminium Hydroxide Adjuvant Initiates Strong Antigen-Specific Th2 Responses in the Absence of IL-4- or IL-13-Mediated Signaling J. Immunol., December 15, 1999; 163(12): 6448 - 6454. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |